Clinical Trial Update: A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for OBE2109 in endometriosis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• OBE2109

Snippet

Sponsor: ObsEva SA | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-21